Patricia Baxter

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Acute Lymphoblastic Leukemia

Placebo Controlled

Top Venues

Neuro-oncology advances

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle Monje, Tabitha Cooney, John W Glod, Jie Huang, Cody J Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan J Robison, Lindsay Kilburn, Anna Vinitsky, William D Figg, Nada Jabado, Maryam Fouladi, Jason R Fangusaro, Arzu Onar-Thomas, Ira J Dunkel, Katherine E Warren
A Phase I Trial of Panobinostat in Children with Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-oncology (2023)
Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse
Phase II study of everolimus for recurrent or progressive pediatric ependymoma. Neuro-oncology advances 5 (1) (2023)
Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse
Phase II study of everolimus for recurrent or progressive pediatric ependymoma. Neuro-oncology advances 5 (1) (2023)
Austin J Stuckert, Eric S Schafer, Melanie Brooke Bernhardt, Patricia Baxter, Julienne Brackett
Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL). Leukemia & lymphoma 61 (5) (2019)